-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Hhno/53XAAYM6hTBb/7tRNmzuY2nxX0mZH2bcROFyX8Z9LG7//E0AYrVjTKZT3Zy LeW2qN+CVJZFo5tlXVDPcA== 0001005477-03-003556.txt : 20030822 0001005477-03-003556.hdr.sgml : 20030822 20030822211431 ACCESSION NUMBER: 0001005477-03-003556 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20021007 FILED AS OF DATE: 20030822 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GUILFORD PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000918066 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521841960 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6611 TRIBUTARY ST CITY: BALTIMORE STATE: MD ZIP: 21224 BUSINESS PHONE: 4106316300 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SACANE SCOTT CENTRAL INDEX KEY: 0001160291 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23736 FILM NUMBER: 03863486 BUSINESS ADDRESS: STREET 1: C/O HIGHLINE MANAGEMENT LLC STREET 2: 888 SEVENTH AVE CITY: NEW YORK STATE: NY ZIP: 10106 BUSINESS PHONE: 2126032600 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DURUS CAPITAL MANAGEMENT CENTRAL INDEX KEY: 0001166014 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23736 FILM NUMBER: 03863487 BUSINESS ADDRESS: STREET 1: 113 POST RD. EAST CITY: VESTPORT STATE: CT ZIP: 06880 BUSINESS PHONE: 2033410667 MAIL ADDRESS: STREET 1: 113 POST RD. EAST CITY: WESTPORT STATE: CT ZIP: 06880 4 1 edgar123.xml FORM 4 X0201 4 2002-10-07 1 0000918066 GUILFORD PHARMACEUTICALS INC GLFD 0001166014 DURUS CAPITAL MANAGEMENT 113 POST RD. EAST WESTPORT CT 06880 0 0 1 0 0001160291 SACANE SCOTT 0 0 1 0 Common Stock 2002-10-31 4 P 0 10000 5.0200 A 2811468 I See Footnote Common Stock 2002-11-01 4 P 0 15527 4.7019 A 2826995 I See Footnote Common Stock 2002-11-01 4 P 0 16000 4.6486 A 2842995 I See Footnote Common Stock 2002-11-04 4 P 0 500 4.8800 A 2843495 I See Footnote Common Stock 2002-11-05 4 P 0 7500 4.8400 A 2850995 I See Footnote Common Stock 2002-11-05 4 P 0 4300 4.8767 A 2855295 I See Footnote Common Stock 2002-11-06 4 P 0 1953 5.1802 A 2857248 I See Footnote Common Stock 2002-11-07 4 P 0 1000 5.1300 A 2858248 I See Footnote Common Stock 2002-11-08 4 P 0 5747 5.0354 A 2863995 I See Footnote Common Stock 2002-11-11 4 P 0 10000 4.9500 A 2873995 I See Footnote Common Stock 2002-11-11 4 P 0 1700 4.7715 A 2875695 I See Footnote Common Stock 2002-11-11 4 P 0 3382 4.7488 A 2879077 I See Footnote Common Stock 2002-11-13 4 P 0 1000 4.8800 A 2880077 I See Footnote Common Stock 2002-11-14 4 P 0 2000 4.8050 A 2882077 I See Footnote Common Stock 2002-11-15 4 P 0 8000 4.6479 A 2890077 I See Footnote Common Stock 2002-11-15 4 P 0 17000 4.5638 A 2907077 I See Footnote Common Stock 2002-11-15 4 P 0 250 4.9850 A 2907327 I See Footnote Common Stock 2002-11-18 4 P 0 500 4.6800 A 2907827 I See Footnote Common Stock 2002-11-18 4 P 0 18100 4.6108 A 2925927 I See Footnote Common Stock 2002-11-19 4 P 0 5750 4.4987 A 2931677 I See Footnote Common Stock 2002-11-20 4 P 0 5350 4.6450 A 2937027 I See Footnote Common Stock 2002-11-20 4 P 0 15000 4.6300 A 2952027 I See Footnote This Form 4 is being filed by Durus Capital Management, LLC ("Capital") and Scott Sacane. Because the SEC's electronic filing system does not allow for the disclosure of more than 30 transactions on one Form 4, the Reporting Persons are filing 2 simultaneous Form 4s to report their reportable transactions all of which together shall be deemed a single report filed on this date. This is the 2nd Form 4 of 2 filings. In accordance with instruction 4(b)(iv) of Form 4, these amounts reflect the aggregate amount of shares controlled by Capital (and by Scott Sacane through Capital) under Section 13(d) of the Exchange Act. Each Reporting Person disclaims beneficial ownership under Section 16 of the Exchange Act with respect to such transactions or securities, as applicable, to the extent greater than their indirect pecuniary interest therein. Through Durus Life Sciences Master Fund Ltd. The Reporting Persons are currently unable to determine the exact time of day that these transactions were effected. The Reporting Persons disclaim the applicability of Section 16 to these transactions to the extent the transactions occurred when Section 16 was inapplicable to such transactions. /s/ Scott Sacane 2003-08-22 EX-99 3 ex99.txt INFORMATION REGARDING JOINT FILERS Exhibit 99 Information Regarding Joint Filers Designated Filer of Form 4: Durus Capital Management, LLC Date of Earliest Transaction Required to be Reported: October 7, 2002 Issuer Name and Ticker Symbol: Guilford Pharmaceuticals Inc. (GLFD) Joint Filer Names and addresses: Scott Sacane, 20 Marshall Street, ste 320, South Norwalk, CT 06854 Durus Capital Management (N.A.), LLC, 20 Marshall Street, ste 320, South Norwalk, CT 06854 Signatures: /s/ Scott Sacane - ---------------- Scott Sacane Durus Capital Management, LLC By: /s/ Scott Sacane ---------------- Name: Scott Sacane Title: Managing Director -----END PRIVACY-ENHANCED MESSAGE-----